BioNTech, which reported it had built up an 18.6 billion euro ($20.55 billion) balance of cash and receivables at the end of March, has pursued a string of takeovers and alliance deals to broaden its work on cancer treatments.
Tag Archive for: BioNTech
The move comes as the bloc plans to revamp laws governing the $148 billion pharmaceuticals industry in the hope of reviving investment and boosting access to affordable drugs at a time when health budgets are drained by the costs of treating COVID-19.
Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus’ patents.
The companies said they will co-develop the candidates DB-1303 and DB-1311 as a combination therapy in solid tumors.
“We plan to continue investing in our transformation with a focus on building commercial capabilities in oncology and working towards registrational trials,” said CEO and Co-Founder Ugur Sahin.
The companies said they will co-develop the candidate, ONC-392, as a monotherapy or as a combination therapy in various cancer indications.
The amended authorization is for children six months through four years of age who have completed their initial three-dose vaccination with Pfizer’s original shot.
Novavax Inc.’s shares plunged 28% in U.S. early trading on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business.
Pfizer Inc. and its German partner BioNTech SE (22UAy.DE) have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday.
The companies are seeking approval of the updated vaccine both as a primary and a booster dose for individuals 12 years and above.
